As the overall industry pipeline of allogeneic T-cell therapies expands, the onus on manufacturers and their partners to adeptly manage the complex cryogenic logistics process intensifies.
Andrea Zobel, PhD
Advertisement
Senior Director, Personalized, Supply Chain, World Courier, a part of Cencora
Articles by Andrea Zobel, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
3
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
4
Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial
5
